SJIA patient characteristics of those who successfully discontinued corticosteroids during Canakinumab treatment: secondary analysis from a pivotal phase 3 trial

G. Horneff; R. Berner; N. Ruperto; H. Brunner; T. Constantin; N. Wulffraat; J. Anton; J. Barash; F. Corona; R. Cuttica; M. Desjonqueres; M. Fischbach; M. Alessio; A. Chieng; W. Emminger; E. Haddad; K. Lheritier; K. Abrams; J. Hruska; D. Kim; A. Martini; D. Lovell

SJIA patient characteristics of those who successfully discontinued corticosteroids during Canakinumab treatment: secondary analysis from a pivotal phase 3 trial

G. Horneff
, R. Berner
, N. Ruperto
, H. Brunner
, T. Constantin
, N. Wulffraat
, J. Anton
, J. Barash
, F. Corona
, R. Cuttica
, M. Desjonqueres
, M. Fischbach
, M. Alessio
, A. Chieng
, W. Emminger
, E. Haddad
, K. Lheritier
, K. Abrams
, J. Hruska
, D. Kim

A. Martini, D. Lovell

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Pages (from-to)	80-81
Journal	Zeitschrift für Rheumatologie
Volume	72
Publication status	Published - Sept 2013

Cite this

Horneff, G., Berner, R., Ruperto, N., Brunner, H., Constantin, T., Wulffraat, N., Anton, J., Barash, J., Corona, F., Cuttica, R., Desjonqueres, M., Fischbach, M., Alessio, M., Chieng, A., Emminger, W., Haddad, E., Lheritier, K., Abrams, K., Hruska, J., ... Lovell, D. (2013). SJIA patient characteristics of those who successfully discontinued corticosteroids during Canakinumab treatment: secondary analysis from a pivotal phase 3 trial. Zeitschrift für Rheumatologie, 72, 80-81.

@article{472458a779504f51b7ceda72acd29f10,

title = "SJIA patient characteristics of those who successfully discontinued corticosteroids during Canakinumab treatment: secondary analysis from a pivotal phase 3 trial",

author = "G. Horneff and R. Berner and N. Ruperto and H. Brunner and T. Constantin and N. Wulffraat and J. Anton and J. Barash and F. Corona and R. Cuttica and M. Desjonqueres and M. Fischbach and M. Alessio and A. Chieng and W. Emminger and E. Haddad and K. Lheritier and K. Abrams and J. Hruska and D. Kim and A. Martini and D. Lovell",

year = "2013",

month = sep,

language = "English",

volume = "72",

pages = "80--81",

journal = "Zeitschrift f{\"u}r Rheumatologie",

issn = "0340-1855",

publisher = "Springer Medizin",

}

Horneff, G, Berner, R, Ruperto, N, Brunner, H, Constantin, T, Wulffraat, N, Anton, J, Barash, J, Corona, F, Cuttica, R, Desjonqueres, M, Fischbach, M, Alessio, M, Chieng, A, Emminger, W, Haddad, E, Lheritier, K, Abrams, K, Hruska, J, Kim, D, Martini, A & Lovell, D 2013, 'SJIA patient characteristics of those who successfully discontinued corticosteroids during Canakinumab treatment: secondary analysis from a pivotal phase 3 trial', Zeitschrift für Rheumatologie, vol. 72, pp. 80-81.

TY - JOUR

T1 - SJIA patient characteristics of those who successfully discontinued corticosteroids during Canakinumab treatment: secondary analysis from a pivotal phase 3 trial

AU - Horneff, G.

AU - Berner, R.

AU - Ruperto, N.

AU - Brunner, H.

AU - Constantin, T.

AU - Wulffraat, N.

AU - Anton, J.

AU - Barash, J.

AU - Corona, F.

AU - Cuttica, R.

AU - Desjonqueres, M.

AU - Fischbach, M.

AU - Alessio, M.

AU - Chieng, A.

AU - Emminger, W.

AU - Haddad, E.

AU - Lheritier, K.

AU - Abrams, K.

AU - Hruska, J.

AU - Kim, D.

AU - Martini, A.

AU - Lovell, D.

PY - 2013/9

Y1 - 2013/9

M3 - Meeting Abstract

SN - 0340-1855

VL - 72

SP - 80

EP - 81

JO - Zeitschrift für Rheumatologie

JF - Zeitschrift für Rheumatologie

ER -